We are live on !
Find out more
Dmitry Balyasny Balyasny Asset Management
AUM
$80.2B
Turnover
42.78%
1-Year Est. Return
51.53%
Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.
This Fund
S&P 500
This Quarter Est. Return
+19.41%
1 Year Est. Return
+51.53%
3 Year Est. Return
+149.76%
5 Year Est. Return
+199.38%
10 Year Est. Return
+875.18%
AUM
$80.2B
AUM Growth
+$3.12B
(+4%)
Cap. Flow
-$3.01B
Cap. Flow % of AUM
Cap. Flow %
-3.76%
Top 10 Holdings %
Top 10 Hldgs %
13.57%
Holding
3,665
New
834
Increased
989
Reduced
995
Closed
734
Avg Time Held
Equity + Options
1.1
years
Top 10 Avg Time Held
Equity + Options
0.8
years
Top 20 Avg Time Held
Equity + Options
0.8
years
Avg Time Held Equity only
0.9
years
Top 10 Avg Time Held Equity only
0.4
years
Top 20 Avg Time Held Equity only
0.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SpaceX
SPCX
|
+$577M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$538M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$517M |
| 4 |
Texas Instruments
TXN
|
+$413M |
| 5 |
Roku
ROKU
|
+$356M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Hologic
HOLX
|
+$357M |
| 2 |
Meta Platforms (Facebook)
META
|
+$326M |
| 3 |
Johnson Controls International
JCI
|
+$303M |
| 4 |
Applied Materials
AMAT
|
+$285M |
| 5 |
Coterra Energy
CTRA
|
+$285M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 36.95% |
| 2 | Technology | 12.69% |
| 3 | Industrials | 10% |
| 4 | Consumer Discretionary | 7.97% |
| 5 | Healthcare | 7.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2251
Velo3D Inc
VELO
$211M
| $778K | ﹤0.01% |
+44,320
| New | +$768K |
2026 Q2
0 quarters
|
|
2252
DTE Energy
DTE
$28.2B
| $777K | ﹤0.01% |
5,102
+2,002
| +65% | +$292K |
2025 Q4
2 quarters
|
|
2253
Sasol
SSL
$11B
| $777K | ﹤0.01% |
79,078
+49,568
| +168% | +$626K |
2026 Q1
1 quarter
|
|
2254
PUT
Amphenol
APH
$196B
| $776K | ﹤0.01% |
8,800
+2,800
| +47% | +$202K |
2026 Q1
1 quarter
|
|
2255
Novavax
NVAX
$1.66B
| $775K | ﹤0.01% |
+82,240
| New | +$737K |
2026 Q2
0 quarters
|
|
2256
Roper Technologies
ROP
$46.1B
| $775K | ﹤0.01% |
2,289
-38,321
| -94% | -$13.1M |
2025 Q1
5 quarters
|
|
2257
Dow Inc
DOW
$25.1B
| $771K | ﹤0.01% |
28,171
-1,458,518
| -98% | -$52.9M |
2025 Q4
2 quarters
|
|
2258
CALL
KeyCorp
KEY
$22.3B
| $770K | ﹤0.01% |
33,400
-300
| -0.9% | -$6.54K |
2025 Q4
2 quarters
|
|
2259
Arch Capital
ACGL
$34.7B
| $766K | ﹤0.01% |
7,894
+2,558
| +48% | +$241K |
2025 Q4
2 quarters
|
|
2260
Veeva Systems
VEEV
$50.7B
| $766K | ﹤0.01% |
4,314
+3,152
| +271% | +$520K |
2024 Q3
7 quarters
|
|
2261
FuelCell Energy
FCEL
$897M
| $764K | ﹤0.01% |
21,223
-72,750
| -77% | -$1.18M |
2025 Q4
2 quarters
|
|
2262
Candel Therapeutics
CADL
$637M
| $757K | ﹤0.01% |
73,495
+30,287
| +70% | +$229K |
2026 Q1
1 quarter
|
|
2263
Ondas Inc
ONDS
$3.68B
| $756K | ﹤0.01% |
91,739
-277,688
| -75% | -$2.74M |
2026 Q1
1 quarter
|
|
2264
CALL
Rocket Lab Corp
RKLB
$35B
| $752K | ﹤0.01% |
+7,400
| New | +$737K |
2026 Q2
0 quarters
|
|
2265
Crown Castle
CCI
$37.7B
| $750K | ﹤0.01% |
9,901
-642,594
| -98% | -$56.4M |
2025 Q4
2 quarters
|
|
2266
PUT
AXT Inc
AXTI
$3.61B
| $750K | ﹤0.01% |
+10,400
| New | +$937K |
2026 Q2
0 quarters
|
|
2267
Twist Bioscience
TWST
$10.1B
| $747K | ﹤0.01% |
7,265
-719,023
| -99% | -$46.8M |
2025 Q1
5 quarters
|
|
2268
PUT
Accenture
ACN
$158B
| $747K | ﹤0.01% |
6,000
-600
| -9% | -$104K |
2023 Q3
11 quarters
|
|
2269
American Water Works
AWK
$28.7B
| $745K | ﹤0.01% |
5,659
+2,746
| +94% | +$353K |
2025 Q3
3 quarters
|
|
2270
PACS Group
PACS
$7.57B
| $744K | ﹤0.01% |
+17,447
| New | +$627K |
2026 Q2
0 quarters
|
|
2271
World Acceptance Corp
WRLD
$766M
| $742K | ﹤0.01% |
+3,313
| New | +$533K |
2026 Q2
0 quarters
|
|
2272
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
$139M
| $735K | ﹤0.01% |
33,263
+16,913
| +103% | +$460K |
2026 Q1
1 quarter
|
|
2273
Canada Goose Holdings
GOOS
$785M
| $734K | ﹤0.01% |
77,173
+24,788
| +47% | +$261K |
2025 Q4
2 quarters
|
|
2274
ImmunityBio
IBRX
$8.79B
| $732K | ﹤0.01% |
83,584
-20,287
| -20% | -$154K |
2025 Q3
3 quarters
|
|
2275
CALL
Nu Holdings
NU
$56.1B
| $728K | ﹤0.01% |
54,500
-1,100
| -2% | -$14.8K |
2025 Q2
4 quarters
|
|
Similar funds
Dmitry Balyasny's Q2 2026 Portfolio in Review
As of Q2 2026, Dmitry Balyasny held 3,665 positions worth $80.2B, up 4% from $77.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Dmitry Balyasny withdrew a net $3.01B in Q2 2026, closing 734 positions and reducing 995 holdings. Its most notable exit was Hologic, an estimated $357M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 37% of assets, down from 39% a quarter earlier, followed by Technology and Industrials.
Against the trend, Dmitry Balyasny opened a new position in SpaceX worth $581M.
- Dmitry Balyasny's largest Q2 2026 buy was SpaceX: 3,397,642 shares worth $581M.
- Dmitry Balyasny added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $538M increase.
- Dmitry Balyasny's biggest Q2 2026 reduction was Meta Platforms (Facebook), cutting an estimated $326M.
- Dmitry Balyasny fully exited Hologic in Q2 2026, selling an estimated $357M.
- Dmitry Balyasny's ten largest holdings make up 14% of its $80.2B portfolio in Q2 2026.
- Dmitry Balyasny opened 834 new positions and closed 734 in Q2 2026.
- Dmitry Balyasny's portfolio value rose 4% quarter-over-quarter to $80.2B.
Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.